After controversial approval, doctors are still debating how to use Biogen’s Alzheimer’s drug
Nearly two months since Aduhelm became available, many physicians have yet to use the first treatment approved in the U.S. to slow Alzheimer’s disease.
Nearly two months since Aduhelm became available, many physicians have yet to use the first treatment approved in the U.S. to slow Alzheimer’s disease.
Hospitals will also receive a 2.5% pay bump for inpatient stays in 2022 under the new rule. That’s lower than the 2.8% proposed in the initial draft released April, but “largely within the range of market expectations,” one analyst wrote.
But researchers cautioned policymakers not to view the results as a reason to avoid reducing Medicare reimbursement.
Health system revenues in June surpassed both 2019 and 2020 levels, though expenses were higher than two years ago, the report found.
After over two decades as head of Americas Technology Banking at Morgan Stanley, Edward Liu will oversee all of the New York-based digital healthcare marketplace’s finances.
A new survey from the Larry A. Green Center and Primary Care Collaborative found that 40% of clinicians worry primary care will be gone in just five years.
Attempts to “defraud the program cannot continue and will be pursued,” DOJ officials said in statement announcing the action against the California-based system.
Some services were near or back to pre-pandemic levels in the second quarter, though others like ER visits are still lagging. At the same time, increasing cases of the delta variant could hinder full recoveries this year.
This feeling of optimism came despite the fact that 11% of independent medical practices said they had shut down temporarily during the COVID-19 crisis, according to a new survey.
Mislabeled patient death reports can go missed by FDA, potentially leading to unsafe devices remaining on the market, a researcher noted. The analysis raises questions about the complex and often opaque reporting system.